Wolverine Asset Management’s Amedisys AMED Stock Holding History

Wolverine Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,966	Closed	-$1.37M	–	1606
2025 Q2	$1.37M	Hold	13,966	–	–	0.01%	621
2025 Q1	$1.29M	Hold	13,966	–	–	0.02%	613
2024 Q4	$1.27M	Sell	13,966 -20,815	-60%	-$1.91M	0.01%	632
2024 Q3	$3.36M	Hold	34,781	–	–	0.04%	376
2024 Q2	$3.19M	Sell	34,781 -400	-1%	-$37.1K	0.04%	391
2024 Q1	$3.24M	Hold	35,181	–	–	0.04%	381
2023 Q4	$3.34M	Buy	35,181 +4,299	+14%	+$402K	0.03%	419
2023 Q3	$2.88M	Buy	30,882 +20,498	+197%	+$1.89M	0.03%	451
2023 Q2	$950K	Buy	+10,384	New	+$852K	0.01%	695

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Asset Management's AMED Position: Q3 2025 in Review

Wolverine Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 13,966 shares — an estimated $1.37M sold.

Wolverine Asset Management first reported a position in AMED in Q2 2023 and held it in 9 quarters. The position peaked at $3.36M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Wolverine Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Wolverine Asset Management sold 13,966 Amedisys shares in Q3 2025, an estimated $1.37M.
Wolverine Asset Management first reported a position in Amedisys in Q2 2023 and held it in 9 quarters.
Wolverine Asset Management's Amedisys position peaked at $3.36M in Q3 2024.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.